- Home
- BFRGW vs EPRT Comparison
BFRGW vs EPRT Comparison
Compare BFRGW & EPRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFRGW
- EPRT
- Stock Information
- Founded
- BFRGW N/A
- EPRT 2016
- Country
- BFRGW United States
- EPRT United States
- Employees
- BFRGW 11
- EPRT N/A
- Industry
- BFRGW Retail: Computer Software & Peripheral Equipment
- EPRT Real Estate Investment Trusts
- Sector
- BFRGW Technology
- EPRT Real Estate
- Exchange
- BFRGW Nasdaq
- EPRT Nasdaq
- Market Cap
- BFRGW N/A
- EPRT N/A
- IPO Year
- BFRGW 2023
- EPRT 2018
- Fundamental
- Price
- BFRGW $0.21
- EPRT $33.49
- Analyst Decision
- BFRGW
- EPRT Strong Buy
- Analyst Count
- BFRGW 0
- EPRT 14
- Target Price
- BFRGW N/A
- EPRT $33.41
- AVG Volume (30 Days)
- BFRGW N/A
- EPRT 1.2M
- Earning Date
- BFRGW N/A
- EPRT 10-23-2024
- Dividend Yield
- BFRGW N/A
- EPRT 3.47%
- EPS Growth
- BFRGW N/A
- EPRT N/A
- EPS
- BFRGW N/A
- EPRT 1.15
- Revenue
- BFRGW N/A
- EPRT $428,535,000.00
- Revenue This Year
- BFRGW N/A
- EPRT N/A
- Revenue Next Year
- BFRGW N/A
- EPRT $18.77
- P/E Ratio
- BFRGW N/A
- EPRT $29.12
- Revenue Growth
- BFRGW N/A
- EPRT 27.83
- 52 Week Low
- BFRGW N/A
- EPRT $23.42
- 52 Week High
- BFRGW N/A
- EPRT $34.51
- Technical
- Relative Strength Index (RSI)
- BFRGW N/A
- EPRT 56.17
- Support Level
- BFRGW N/A
- EPRT $32.47
- Resistance Level
- BFRGW N/A
- EPRT $34.19
- Average True Range (ATR)
- BFRGW 0.00
- EPRT 0.75
- MACD
- BFRGW 0.00
- EPRT 0.13
- Stochastic Oscillator
- BFRGW 0.00
- EPRT 75.00
About BFRGW Bullfrog AI Holdings Inc.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.